About J. Strattan
Form D filings for Talus Bioscience in 2024 list J. Strattan as director.
J. Strattan first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name J. Strattan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people J. Strattan works with at each company, as listed on that company's latest Form D.
Talus Bioscience, Inc. · Form D, Aug 12, 2024
LP
Lindsay Pino
Executive officer and director
MB
Michelle Briscoe
Chief Operating Officer
AF
Alex Federation
Executive officer, director and promoter
OD
Omri Amirav-Drory
Director